The ITGB3 protein, known as the integrin beta chain beta 3, was identified as an epithelial-to-mesenchymal transition biomarker in colorectal cancer, prostate cancer, and breast cancer [31, 32]. Here, ITGB3 is linked to breast carcinoma.